It is, therefore, imperative for drug manufacturers to ensure that formulations enclosed in primary containers are safe for consumption / administration.New York, March 09, 2022 (GLOBE NEWSWIRE) -- ...
At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...
EXTON, Pa., Oct. 29, 2013 /PRNewswire/ -- West , a leading global manufacturer of components and systems for injectable drug delivery, today announced the first peer-reviewed data demonstrating the ...
Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures. For biologic drug products that require frozen storage—even down to cryogenic ...
The Indian pharmaceutical industry is of the view that the recent US FDA norms on container closure system will enhance quality and reliability of drug’s shelf-life. The manufacturers emphasize that ...
All sterile drug manufacturer is required to check and demonstrate their manufacturing systems capable of maintaining container and closure barrier integrity throughout the product life cycle. As such ...
The document includes recommendations for the reporting and implementation of changes to container closure system components. On Nov. 7, 2023, FDA issued final guidance that includes recommendations ...
New York, March 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Container Closure Integrity Testing Services Market by Type of Container Closure Systems, Type of ...
It is, therefore, imperative for drug manufacturers to ensure that formulations enclosed in primary containers are safe for consumption / administration.New York, March 10, 2022 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results